SpyderByte.com ;Technical Portals 
      
 News & Information Related to Linux High Performance Computing, Linux Clustering and Cloud Computing
Home About News Archives Contribute News, Articles, Press Releases Mobile Edition Contact Advertising/Sponsorship Search Privacy
HPC Vendors
Cluster Quoter (HPC Cluster RFQ)
Hardware Vendors
Software Vendors
HPC Consultants
Training Vendors
HPC Resources
Featured Articles
Cluster Builder
Beginners
Whitepapers
Documentation
Software
Lists/Newsgroups
Books
User Groups & Organizations
HP Server Diagrams
HPC News
Latest News
Newsletter
News Archives
Search Archives
HPC Links
ClusterMonkey.net
Scalability.org
HPCCommunity.org

Beowulf.org
HPC Tech Forum (was BW-BUG)
Gelato.org
The Aggregate
Top500.org
Cluster Computing Info Centre
Coyote Gultch
Dr. Robert Brown's Beowulf Page
FreshMeat.net: HPC Software
SuperComputingOnline
HPC User Forum
GridsWatch
HPC Newsletters
Stay current on Linux HPC news, events and information.
LinuxHPC.org Newsletter

Other Mailing Lists:
Linux High Availability
Beowulf Mailing List
Gelato.org (Linux Itanium)

LinuxHPC.org
Home
About
Contact
Mobile Edition
Sponsorship

Latest News

Boehringer Ingelheim Pharmaceuticals Uses Linux NetworX Cluster to Aid in Drug Discovery
Posted by Kenneth Farmer, Tuesday April 02 2002 @ 08:28AM EST

Linux Cluster Helps Pharmaceutical Company Improve Efficiency and Save Time

SALT LAKE CITY, UTAH, April 2, 2002 - Linux NetworX announced today that Boehringer Ingelheim Pharmaceuticals, Inc. is advancing its human healthcare research and development processes with a 120-processor Linux NetworX Evolocity cluster supercomputer.

The Ridgefield, Conn. laboratory of Boehringer Ingelheim Pharmaceuticals is using the cluster supercomputer to help predict the suitability of certain molecules in potential drugs. This process is ideal for a Linux cluster supercomputer because the same compute process is completed for hundreds of thousands of molecules. Computational chemists and biologists at Boehringer Ingelheim Pharmaceuticals are also using the cluster to run applications to find the best combinations of molecules and protein binding sites for drug development.

"With a 120-processor cluster, managing every aspect of the system can be quite overwhelming," said Dave Craska, lead systems engineer for Boehringer Ingelheim Pharmaceuticals, Inc. "The ClusterWorX software from Linux NetworX helps alleviate the complexities of cluster management, especially when upgrading and propagating new releases of software."

Before switching to a Linux NetworX cluster, scientists at Boehringer Ingelheim Pharmaceuticals were running the same applications on a variety of systems, but results were slowed because of the limited number of available CPUs. After deploying the Linux NetworX cluster, information was processed quickly and efficiently, saving Boehringer Ingelheim Pharmaceuticals time and money.

The massive amount of data computation inherent in drug design typically requires the power of a supercomputer class system. Cluster technology is a method of linking multiple computers, or compute nodes, together to form a powerful, unified system. Linux NetworX clusters can match the performance of traditional supercomputers for a fraction of the cost.

"The bioinformatics industry is experiencing an enormous demand for cost-effective, reliable supercomputing solutions and many pharmaceutical companies are turning to Linux clusters to meet that need," said Clark Roundy, vice president of marketing at Linux NetworX. "Companies such as Boehringer Ingelheim Pharmaceuticals demand quick, accurate results and Linux NetworX provides the management tools to ensure our customers focus on their core competencies instead of system management."

Boehringer Ingelheim Pharmaceuticals Evolocity system includes 120 Pentium III 866 MHz processors, 50 GB of memory, an Intel 10/100 NIC connection and ClusterWorX cluster management software. To ensure optimum cluster operation, Boehringer Ingelheim Pharmaceuticals also signed a service and support contract with Linux NetworX.

About Boehringer Ingelheim Pharmaceuticals

Boehringer Ingelheim Pharmaceuticals, Inc., based in Ridgefield, CT, is the largest U.S. subsidiary of Boehringer Ingelheim Corporation (Ridgefield, CT) and a member of the Boehringer Ingelheim group of companies. The Boehringer Ingelheim group of companies, with headquarters in Ingelheim (Germany) is one of the 20 leading pharmaceutical firms in the world and reported revenues of almost US $5.8 billion in 2000. Boehringer Ingelheim, which has some 140 affiliated companies worldwide, focuses on human pharmaceuticals and animal health. The human pharmaceuticals business, which accounts for 95% of sales, is comprised of prescription medicines, consumer health care products and chemicals and biopharmaceuticals for industrial customers . Research and development, production, and distribution facilities are located around the globe. In 2000, Boehringer Ingelheim spent almost US $914 million on R&D, equivalent to 15.6% of net sales.

For more information on Boehringer Ingelheim, please see the international Internet website www.boehringer-ingelheim.com

About Linux NetworX

Linux NetworX (www.linuxnetworx.com) brings its powerful and easy-to-manage cluster technology to those demanding high performance and high availability systems. Linux NetworX provides solutions for organizations involved in oil and gas exploration, aeronautical and chemical modeling, biotechnology research, graphics rendering and visual effects, Web serving, ISPs, ASPs, and other technological research fields. Through its innovative Evolocity hardware, ICE cluster management tools and professional service and support, Linux NetworX provides end-to-end clustering solutions. To date, the company has built some of the largest cluster systems in the world, and boasts numerous Fortune 500 customers.

###
CONTACT:
Brad Rutledge
Linux NetworX
801-562-1010 ext. 218
brutledge@linuxnetworx.com


< PRNewsWire: Compaq Computer Corporation Implements MetiLinx iSystem Enterprise Product | Powerful Eight Processor Cluster Provides SAIC with Highly Effective Solution >

 

Affiliates

Cluster Monkey

HPC Community


Supercomputing 2010

- Supercomputing 2010 website...

- 2010 Beowulf Bash

- SC10 hits YouTube!

- Louisiana Governor Jindal Proclaims the week of November 14th "Supercomputing Week" in honor of SC10!








Appro: High Performance Computing Resources
IDC: Appro Xtreme-X Supercomputer Blade Solution
Analysis of the Xtreme-X architecture and management system while assessing challenges and opportunities in the technical computing market for blade servers.

Video - The Road to PetaFlop Computing
Explore the Scalable Unit concept where multiple clusters of various sizes can be rapidly built and deployed into production. This new architectural approach yields many subtle benefits to dramatically lower total cost of ownership.
White Paper - Optimized HPC Performance
Multi-core processors provide a unique set of challenges and opportunities for the HPC market. Discover MPI strategies for the Next-Generation Quad-Core Processors.

Appro and the Three National Laboratories
[Appro delivers a new breed of highly scalable, dynamic, reliable and effective Linux clusters to create the next generation of supercomputers for the National Laboratories.

AMD Opteron-based products | Intel Xeon-based products



Home About News Archives Contribute News, Articles, Press Releases Mobile Edition Contact Advertising/Sponsorship Search Privacy
     Copyright © 2001-2013 LinuxHPC.org
Linux is a trademark of Linus Torvalds
All other trademarks are those of their owners.
    
  SpyderByte.com ;Technical Portals